The Onconova Therapeutics, Inc., ONTX has Loss (↓) on Friday, January 31, 2020 the stock price is settled at $0.34 after buying and selling hours while rehearsed a difference of -4.75 percent. The stock has a fifty two-week low of $232.04 percent while its fifty two-weeks high are $-92.93 percent.
The total market cap for the stock is $47.82M while it has a PE ratio of 0. Active investor focuses on important indicators rehearsed a difference in session that includes where the Onconova Therapeutics, Inc..
Each buying and selling session display one-of-a-kind actions and patterns about Onconova Therapeutics, Inc. (ONTX) stock. Presently we watched the different factors that seen on close of last session. Toward the day’s end, it’s only a stock’s exhibition that issues.
Onconova Therapeutics, Inc.’s overall performance:
The performance of the stock during the last 7.00 days was -10.17 percent,
during the last one-month price index is -10.97 percent while over the 3.00 months is -37.1 percent.
Its 6.00 months performance has been -85.97 percent while for the beyond 52.00 weeks is -89 percent.
We have additionally seen that the stock is exchanging -0.98 percent away from the 50-day MA and -81.92 percent of the 20-day MA.
How much shares are traded?
The stock traded hands with 8158955 numbers of shares contrast to its normal every day volume of 18.28M shares.
What amount of stock is unpredictable?
Beta factor was seen at 2.71. Beta estimates the hazard of the security. High beta >1 means implies higher dangerous and low beta <1 shows low peril. The stock remained 6.58 percent erratic for the ongoing week and 11.89 percent for the last month.
Onconova Therapeutics, Inc. has a P/S and P/B values of 21.74 and 0 respectively. Its P/Cash valued at 9.96. The ONTX has PEG of 0. Technical indicators do not lead us to assume the stock will see more gains anytime soon.
Analyst’s mean target amount for the company is 13.77 while analysts mean suggestion is 2.2.